Despite its loud anti-piracy notice, Andrey Fedotov's HackStore sees no issue in ripping off the official App Store's interface. Nevertheless, its aim is to gather up legit and readily available apps that didn't make it past Apple's trellis for whatever reason, and hopefully with Fedotov keeping an eye out for malware. You'll find FileZilla, Gimp and many rarer specimens -- and they're all just regular .dmg files so there's actually no hacking involved. That said, we downloaded the RTF to ePUB Converter and then struggled to make it run, so we're not ready to vouch for HackStore's ease-of-use any more than its security or legality. All we're saying, officer, is that it exists.
Although Google most recently pushed out a critical bug fix for Google Maps, they've wasted no time un rolling out the next update. The changes are fairly small in nature, but for some folks it may improve the usage of the app overall and that's always a good thing. As noted in the Google Play Store, the changes this time around are:
Elevation data added to "Measure" Lab
Scale bar and zoom buttons graduate from Labs into Settings
The update is now live in the Google Play Store, so hit the link below to get updated or just simply fire up the store on your device and head to you're "My Apps" section.
Indeed, the Curve 9320's been anything but shy in these past couple of months. First, it was spotted while on a purported trip to India and shortly after that posing for T-Mobile's UK site. Now, the BlackBerry handset has been pampered by a full hands-on treatment from the Vietnamese folks over at Sohoa. Unlike its other adventures, though, this one presents far less speculation. As we'd previously heard, the device is in fact running BlackBerry OS 7.1, as well as being equipped with that undisclosed single-core CPU, 512MB of RAM, 3.2-megapixel rear shooter and a 1450mAh battery. Per the translation, Sohoa also notes the Curve 9320 offers a "better keyboard" and is thinner than the rest of the Curve lineup. There's an extra photo for your viewing pleasure after the break, but for the entire rundown be sure to check out the the source link below.
Just a week after NASA signed off on its launch, SpaceX has had to postpone the flight of the Dragon. It's yet another delay to NASA's efforts to supply the International Space Station using private spacecraft and reduce the US's dependence on Soyuz rockets. Taking to Twitter, founder Elon Musk said that the company needed to do more testing on the docking code for the capsule, while spokesperson Kirstin Brost Grantham told Space.com that the company needed more time to test and review the hardware. Pending NASA's approval, it'll begin its journey heavenward on the head of a Falcon 9 between May 3rd and May 7th. Given that the original mission was scheduled for November last year, they'll probably need to check the use-by dates on those space rations.
Kim and Kanye were spotted strolling through New York City over the weekend while Kardashian enjoyed an ice cream cone and sported earrings bearing West's initials, "KW." The couple attended dinner at Spice Market with other members of the Kardashian clan following that outing, and on Monday night, they were photographed again, holding hands while making the rounds in NYC.
First, they attended a dinner thrown by luxury brand Audemars Piguet at Catch in New York's Meatpacking District, where they hung out with Kardashian's pal La La, her husband Carmelo Anthony and producer Swizz Beatz.
Next, they headed out to the opening of Scott Disick's new Japanese restaurant Ryu, where they met up with Kourtney Kardashian, Khloé Kardashian, Lamar Odom and Rob Kardashian. According to New York's Daily News, West kept his arm wrapped around Kim in the back of the restaurant during the festivities, while cameras filmed segments for "Keeping Up With the Kardashians." Later, they were spotted holding hands as they exited the party.
Kardashian tweeted about the opening, writing, "So much fun at Scott's restaurant opening of RYU last night! CONGRATS @ScottDisick We love you! Food was delish!" but she mentioned nothing about the rumors that have continued to swirl about her and Kanye West.
During a Sunday appearance on Bravo's "Watch What Happens Live," Khloé addressed her sister's status with Kanye. "I don't think it's serious. I think it's too soon," she said. "Because they're friends for so long, it's so easy. That's something that I love seeing about Kim, the easiness and how happy she is. It's just more of a great friendship and friendships make the best relationships."
Khloé also commented on rumors that Kanye would appear on the upcoming season of "Keeping Up With the Kardashians," which premieres May 20. "No one has to be on camera. It's not like we're driven to slavery," Khloé said. "Everyone has the option, except for us."
What do you think of Kim and Kanye's relationship? Let us know in the comments!
Despite her recent nightclub altercation (and the other, strikingly similar recent nightclub altercation) Lindsay Lohan is set to star as the legendary Elizabeth Taylor in the Lifetime original movie Liz & Dick, the network itself confirms.
Filming will begin in early June in Los Angeles, with LiLo as Liz.
For nearly a quarter of a century, Taylor and Richard Burton were Hollywood royalty and the fiery romance they shared was often called “the marriage of the century.”
It was the most notorious, publicized and celebrated love affair of its day.
Swarmed by press, Taylor and Burton’s love affair was one of the first romances to play out in the public eye ... something celebrity gossip staple Lohan can relate to.
Says Lifetime of the film and its lead:
"Despite their roller coaster romance for the public eye to see, Taylor and Burton shared an undeniable love greater than most people could have dreamed."
Regarding the announcement, Lohan said:
“I have always admired and had enormous respect for Elizabeth Taylor. She was not only an incredible actress but an amazing woman as well."
"I am very honored to have been asked to play this role.”
“We are thrilled Lindsay will portray beloved Hollywood legend Elizabeth Taylor,” added the network. “She is one of the rare actresses who possesses the talent, beauty and intrigue to capture the spirit of such a provocative icon.”
IU Simon Cancer Center joins WellPoint in developing health care solutionsPublic release date: 23-Apr-2012 [ | E-mail | Share ]
Contact: Michael Schug maschug@iupui.edu 317-278-0953 Indiana University School of Medicine
INDIANAPOLIS -- WellPoint announced today that Indiana University Melvin and Bren Simon Cancer Center will provide clinical expertise to help shape WellPoint's new health care solutions.
WellPoint announced plans in September to develop commercial applications utilizing IBM Watson to help improve patient care and support physicians in their efforts to make the most informed, personalized treatment decisions possible. It is estimated that new clinical research and medical information doubles every five years, and nowhere is this knowledge advancing more quickly than in the complex area of cancer care.
WellPoint believes oncology is one of the medical fields that could greatly benefit from this technology, given IBM Watson's ability to respond to inquiries posed in natural language and to learn from the responses it generates. The WellPoint health care solutions will draw from vast libraries of information, including medical evidence-based scientific and health care data, and clinical insights from institutions like Indiana University. The goal is to assist physicians in evaluating evidence-based treatment options that can be delivered to the physician in a matter of seconds for assessment. WellPoint and the IU Simon Cancer Center envision that this valuable enhancement to the decision-making process could empower physician-patient discussions about the best and most effective courses of treatment and improve the overall quality of patient care.
The IU Simon Cancer Center was selected as WellPoint's partner and clinical consultant based on its reputation as one of the nation's premier cancer institutions and its proven results in the diagnosis and treatment of complex cancers. IU Simon Cancer Center has experience and demonstrated success in working with technology innovators and shares WellPoint's commitment to improving the quality, efficiency and effectiveness of health care through innovation and technology.
IU Simon Cancer Center experts will help develop recommendations on appropriate clinical content for the WellPoint health care solutions. They will also assist in the evaluation and testing of the specific tools that WellPoint plans to develop for the oncology field. The cancer experts will provide guidance on how to improve the content and utility of the treatment options provided to the physicians using the new technology and will also become early adopters in piloting the system.
Leading the IU Simon Cancer Center's efforts are George W. Sledge, Jr., MD, and Patrick J. Loehrer, Sr., MD. They will work closely with WellPoint's clinical experts, and with IU's trusted informatics partner, the Regenstrief Institute, to provide advice on how the solutions may be best utilized in clinical practice to support increased understanding of the evolving body of knowledge in cancer, including emerging therapies not widely known by community physicians. As the solutions are developed, Drs. Sledge and Loehrer will also provide guidance to WellPoint.
"As we design the WellPoint systems that leverage IBM Watson's capabilities, it is essential that we incorporate the highly-specialized knowledge and real-life practice experiences of the nation's premier clinical experts," said Harlan Levine, MD, executive vice president of WellPoint's Comprehensive Health Solutions. "The contributions from Dr. Sledge and Dr. Loehrer, coupled with the expertise throughout the IU Simon Cancer Center, will be invaluable to implementing this WellPoint offering and could ultimately benefit millions of Americans across the country."
"Researchers from the IU Simon Cancer Center are leading clinical investigators who have set standards of care for treatment of numerous malignancies, including germ cell tumors, breast and thoracic tumors," said Dr. Loehrer, director of the IU Simon Cancer Center and HH Gregg Professor of Oncology at the IU School of Medicine. "We will also be working closely with experts at the Regenstrief Institute -- an internationally respected informatics and healthcare organization -- whose scientists were among the first in the nation to establish electronic medical records. Together, our organizations have a longstanding history of impacting patient care with clinical research."
WellPoint anticipates deploying its first offering later this year, working with select physician groups in clinical pilots.
###
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
IU Simon Cancer Center joins WellPoint in developing health care solutionsPublic release date: 23-Apr-2012 [ | E-mail | Share ]
Contact: Michael Schug maschug@iupui.edu 317-278-0953 Indiana University School of Medicine
INDIANAPOLIS -- WellPoint announced today that Indiana University Melvin and Bren Simon Cancer Center will provide clinical expertise to help shape WellPoint's new health care solutions.
WellPoint announced plans in September to develop commercial applications utilizing IBM Watson to help improve patient care and support physicians in their efforts to make the most informed, personalized treatment decisions possible. It is estimated that new clinical research and medical information doubles every five years, and nowhere is this knowledge advancing more quickly than in the complex area of cancer care.
WellPoint believes oncology is one of the medical fields that could greatly benefit from this technology, given IBM Watson's ability to respond to inquiries posed in natural language and to learn from the responses it generates. The WellPoint health care solutions will draw from vast libraries of information, including medical evidence-based scientific and health care data, and clinical insights from institutions like Indiana University. The goal is to assist physicians in evaluating evidence-based treatment options that can be delivered to the physician in a matter of seconds for assessment. WellPoint and the IU Simon Cancer Center envision that this valuable enhancement to the decision-making process could empower physician-patient discussions about the best and most effective courses of treatment and improve the overall quality of patient care.
The IU Simon Cancer Center was selected as WellPoint's partner and clinical consultant based on its reputation as one of the nation's premier cancer institutions and its proven results in the diagnosis and treatment of complex cancers. IU Simon Cancer Center has experience and demonstrated success in working with technology innovators and shares WellPoint's commitment to improving the quality, efficiency and effectiveness of health care through innovation and technology.
IU Simon Cancer Center experts will help develop recommendations on appropriate clinical content for the WellPoint health care solutions. They will also assist in the evaluation and testing of the specific tools that WellPoint plans to develop for the oncology field. The cancer experts will provide guidance on how to improve the content and utility of the treatment options provided to the physicians using the new technology and will also become early adopters in piloting the system.
Leading the IU Simon Cancer Center's efforts are George W. Sledge, Jr., MD, and Patrick J. Loehrer, Sr., MD. They will work closely with WellPoint's clinical experts, and with IU's trusted informatics partner, the Regenstrief Institute, to provide advice on how the solutions may be best utilized in clinical practice to support increased understanding of the evolving body of knowledge in cancer, including emerging therapies not widely known by community physicians. As the solutions are developed, Drs. Sledge and Loehrer will also provide guidance to WellPoint.
"As we design the WellPoint systems that leverage IBM Watson's capabilities, it is essential that we incorporate the highly-specialized knowledge and real-life practice experiences of the nation's premier clinical experts," said Harlan Levine, MD, executive vice president of WellPoint's Comprehensive Health Solutions. "The contributions from Dr. Sledge and Dr. Loehrer, coupled with the expertise throughout the IU Simon Cancer Center, will be invaluable to implementing this WellPoint offering and could ultimately benefit millions of Americans across the country."
"Researchers from the IU Simon Cancer Center are leading clinical investigators who have set standards of care for treatment of numerous malignancies, including germ cell tumors, breast and thoracic tumors," said Dr. Loehrer, director of the IU Simon Cancer Center and HH Gregg Professor of Oncology at the IU School of Medicine. "We will also be working closely with experts at the Regenstrief Institute -- an internationally respected informatics and healthcare organization -- whose scientists were among the first in the nation to establish electronic medical records. Together, our organizations have a longstanding history of impacting patient care with clinical research."
WellPoint anticipates deploying its first offering later this year, working with select physician groups in clinical pilots.
###
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
REYKJAVIK (Reuters) - Iceland's former prime minister was found innocent on Monday of three major charges of negligence related to the country's 2008 economic collapse, and guilty of a smaller count that carried no prison sentence.
The verdict by a special court was seen by many as little more than a slap on the wrist for Geir Haarde, the only leader in the world to face prosecution over the global crisis. He had faced up to two years in prison if found guilty of the more serious charges, including neglecting to deal with an overblown banking sector.
Haarde looked on and showed no visible emotion as the 15-judge court issued its verdict, convicting him of failing to hold dedicated cabinet meetings ahead of the crisis. About 70 people, including his family and political supporters, attended the session.
Moments later, he told reporters that the judges had tried to appease a public opinion angry at a political elite perceived as fostering an unsustainable banking system that grew to 10 times Iceland's GDP just before the meltdown.
"It is absurd," a furious-looking, red-faced Haarde said.
"It is obvious that the majority of the judges have found themselves pressed to come up with a guilty verdict on one point, however minor, to save the neck of the parliamentarians who instigated this," he added.
Outside the court, a protester banged on a pot, in a repeat of the gesture that Icelanders carried out at the height of the crisis in the streets outside parliament. The protests were the biggest ever seen in Iceland, occasionally turning violent in a nation renowned for its peaceful nature.
All of Iceland's top banks went under in 2008 just days after the collapse of Lehman Brothers, which led to a freeze on global interbank lending. The country's crown currency nosedived and many Icelanders who had taken out foreign currency loans found themselves saddled with even bigger piles of debt.
Despite the anger, many Icelanders say the 61-year-old Haarde, generally seen as a decent person who was too soft in his role as prime minister, should not have been the only politician put on the stand.
"He was the captain on the bridge, but there were more ministers," said Arni Einarsson, a pensioner. "The politicians thought that Iceland was like the Titanic - unsinkable."
"NOT UNIQUE"
Prime Minister Johanna Sigurdardottir, who served in Haarde's cabinet during the boom years that preceded the crisis, said the verdict had taken her by surprise.
"I never thought the charges were sufficient to warrant the indictment and subsequent trial," she told state television.
Haarde said that while his government could have done something different in the run up to the island's worst-ever crisis, he doubted he could have stopped it.
"Look at what the leaders of the central banks of the U.S., the UK have said repeatedly - they didn't see this crisis coming. The IMF didn't see this crisis coming," he told Reuters after the verdict, which was broadcast live on TV.
"Look at what is happening in Greece, Spain, Portugal, Ireland, Italy. Our situation is not unique."
Haarde, who had pleaded innocent to all charges, said he is considering taking his case to the European Court of Human Rights.
Eirikur Bergmann, political science professor at the Bifrost University north of the capital, called the ruling "a slap on the wrist".
"He's not convicted on any of the charges leading up to the crisis - sponsoring the system that proved unsustainable," said Bergmann. "It is an in-between ruling to calm both sides of society."
Though the economy is recovering from the crisis and Iceland successfully completed a bailout program led by the International Monetary Fund, people remain distrustful of state institutions. Polls show that parliament has the support of only 10 percent of the public.
Capital controls remain in place, damaging the economic recovery.
(Writing by Alistair Scrutton, additional reporting by Omar Valdimarsson in Reykjavik and Anna Ringstrom and Niklas Pollard in Stockholm; Editing by Alessandra Rizzo)
Potential bad news to start out the week for Microsofties: a judge from the US International Trade Commission has issued a preliminary ruling that finds Microsoft's Xbox 360 infringes on five of Motorola's patents. While the decision is by no means final -- which means that the Redmond outfit could ultimately prevail -- a final ruling would force Microsoft's hand to seek proper licenses for the technologies, most of which relate to H.264 video encoding, or have its gaming console banned from US shelves. For now, the lawyers will go back to the lab to refine their arguments and get ready to present them to a full panel of ITC judges later this year. Who wants to set odds on the outcome?
iJailbreak | 
HackStore | Email this | Comments 
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 23-Apr-2012
Share ] 